---
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/264951622.md"
description: "Pfizer and Metsera signed an amendment to the merger agreement, and the Metsera board reiterated its support for the merger with Pfizer. Pfizer will acquire Metsera for $65.60 in cash per share plus a contingent value right of up to $20.65"
datetime: "2025-11-08T02:42:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264951622.md)
  - [en](https://longbridge.com/en/news/264951622.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264951622.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/264951622.md) | [English](https://longbridge.com/en/news/264951622.md)


# 

Pfizer and Metsera signed an amendment to the merger agreement, and Metsera's board reiterated its support for the merger with Pfizer. Pfizer will acquire Metsera for $65.60 in cash per share plus up to $20.65 in contingent value rights

### 相關股票

- [Pfizer (PFE.US)](https://longbridge.com/zh-HK/quote/PFE.US.md)
- [Metsera (MTSR.US)](https://longbridge.com/zh-HK/quote/MTSR.US.md)

## 相關資訊與研究

- [Pfizer’s Swedish Ibrance Study: Fresh Real‑World Data Signal for PFE Investors](https://longbridge.com/zh-HK/news/281219504.md)
- [Pfizer announces positive results from Breakwater trial cohort 3](https://longbridge.com/zh-HK/news/272155925.md)
- [Why Pfizer's 2026 guidance miss is 'not a major surprise'](https://longbridge.com/zh-HK/news/269888057.md)
- [(PFE) Pfizer Expects 2026 Adjusted EPS Range $2.80 to $3, vs. FactSet Est of $3.05](https://longbridge.com/zh-HK/news/269859022.md)
- [Pfizer CEO says expects to launch next-gen obesity assets acquired through Metsera buyout in 2028: JPM Conf](https://longbridge.com/zh-HK/news/272307224.md)